Venographic comparison of subcutaneous low-molecular weight heparin with oral anticoagulant therapy in the long-term treatment of deep venous thrombosis

Journal of Vascular Surgery

Volumn 30, Issue 2, 1999, Pages 283-292

  Gonzalez Fajardo, J A ^a   Arreba, E ^a   Castrodeza, J ^a   Perez, J L ^a   Fernandez, L ^a   Agundez, I ^a   Mateo, A M ^a   Carrera, S ^a   Gutierrez, V ^a   Vaquero, C ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

COUMARIN ANTICOAGULANT; ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; AGED; ARTICLE; BLEEDING; CANCER; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PHLEBOGRAPHY; PRIORITY JOURNAL; RISK FACTOR; SCORING SYSTEM; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

EID: 0032856855     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0741-5214(99)70139-4     Document Type: Article

References (31)

1. RD Hull GE Raskob GF Pineo Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis N Engl J Med 326 1992 975 982
2. P Prandoni AWA Lensing HR Büller Comparison of subcutaneous low-molecular-weight heparin with intravenous standard heparin in proximaal deep-vein thrombosis Lancet 339 1992 441 445
3. S Lopaciuk AJ Meissner S Filipecki Subcutaneous low molecular weight heparin versus subcutaneous unfractionated heparin in the treatment of deep vein thrombosis: a Polish multicenter trial Thromb Haemost 68 1992 14 18
4. A Collaborative European Multicentre Study A randomised trial of subcutaneous low molecular weight heparin (CY 216) compared with intravenous unfractionated heparin in the treatment of deep vein thrombosis Thromb Haemost 65 1991 251 256
5. DW Hommes A Bura L Mazzolai HR Büller JW ten Cate Subcutaneous heparin compared with continuous intravenous heparin administration in the initial treatment of deep vein thrombosis. A meta-analysis Ann Intern Med 116 1992 279 284
6. AW Lensing MH Prins BL Davidson J. Hirsh Treatment of deep venous thrombosis with low-molecular-weight heparin: a meta-analysis Arch Intern Med 155 1995 601 607
7. M Levine M Gent J Hirsh A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis N Engl J Med 334 1996 677 681
8. MMW Koopman P Prandoni F Piovella Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home N Engl J Med 334 1996 682 687
9. J Hirsh M. Crowther Low molecular weight heparin for the out-of-hospital treatment of venous thrombosis: rationale and clinical results Thromb Haemost 78 1997 689 692
10. K Luomanmäki S Grankvist C Hallert A multicentre comparison of once-daily subcutaneous dalteparin (low molecular weight heparin) and continuous intravenous heparin in the treatment of deep venous thrombosis J Intern Med 240 1996 85 92
11. AGG. Turpie Management of venous thromboembolism: optimization by clinical trials Haemostasis 26 1996 220 226
12. M Monreal E Lafoz A Olive L del Rio C Vedia Comparison of subcutaneous unfractionated heparin with a low molecular weight heparin (Fragmin®) in patients with venous thromboembolism and contraindications to coumarin Thromb Haemost 71 1994 7 11
13. M. Pini Prevention of recurrences after deep venous thrombosis: role of low-molecular-weight heparins Semin Thromb Hemost 23 1997 51 54
14. J. Hirsh Comparison of the relative efficacy and safety of low molecular weight heparin and unfractionated heparin for the treatment of venous thrombosis Haemostasis 26 1996 189 198
15. M Pini C Aiello C Manotti Low molecular weight heparin versus warfarin in the prevention of recurrences after deep vein thrombosis Thromb Haemost 72 1994 191 197
16. VV. Kakkar Dalteparin prevention of recurrent DVT. A study versus warfarin [abstract] Haemostasis 24 Suppl 1 1994 S45
17. M Holmström P Lindmarker S Granqvist H Johnsson D Lackner A 6-month venographic follow-up in 164 patients with acute deep vein thrombosis Thromb Haemost 78 1997 803 807
18. RB. Rutherford Pathogenesis and pathophysiology of the post-thrombotic syndrome: clinical implications? Semin Vasc Surg 9 1996 21 25
19. HK. Breddin Treatment of deep vein thrombosis: is thrombosis regression a desirable endpoints? Semin Thromb Hemost 23 1997 179 183
20. A Gallus J Jackaman J Tillet W Mills A. Wycherley Safety and efficacy of warfarin started early after submassive venous thrombosis or pulmonary embolism Lancet 2 1986 1293 1296
21. RD Hull GE Raskob D Rosenbloom Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosis N Engl J Med 322 1990 1260 1264
22. K Rabinov S. Paulin Roentgen diagnosis of venous thrombosis in the leg Arch Surg 104 1972 134 144
23. VJ Marder RL Soulen V Atichartakarn Quantitative venographic assessment of deep vein thrombosis in the evaluation of streptokinase and heparin therapy J Lab Clin Med 89 1977 1018 1029
24. P Lindmarker M Holmström S Granqvist H Johnsson Comparison of once-daily subcutaneous Fragmin with continuous intravenous unfractionated heparin in the treatment of deep vein thrombosis Thromb Haemost 72 1994 186 190
25. M Mirshahi J Soria E Neuhart Effect of heparin and enoxaparin on platelet interaction with fibrin clots Thromb Res 65 1992 187 191
26. CW. Francis The fibrinolytic system: normal physiology and pathophysiology 1st ed AJ Comerota Thrombolytic therapy for peripheral vascular disease 1995 : J.B. Lippincott Company Philadelphia 25 40
27. EG Vairel H Bouty-Boye F Toulemonde C Doutremepuich NA Marsh PJ. Gaffney Heparin and a low molecular weight fraction enhances thrombolysis and by this pathway exercises a protective effect against thrombosis Thromb Res 30 1983 219 224
28. HP Klocking F. Markwardt Pharmacological stimulation of t-PA release Pharmazie 49 1994 227 230
29. HK Breddin Low molecular weight heparins—state-of-the-art and unsolved issues Blood Coagul Fibrinolysis 4 Suppl 1 1993 S17 S19
30. S Haas P. Haas The efficacy of low molecular weight heparins 1st ed D Bergqvist AJ Comerota AN Nicolaides JH Scurr Prevention of venous thromboembolism 1994 : Med-Orion Nicosia 149 161
31. HK Nielsen SE Husted LR Krusell H Fasting P Charles HH. Hansen Silent pulmonary embolism in patients with deep venous thrombosis. Incidence and fate in a randomized, controlled trial of anticoagulation versus no anticoagulation J Intern Med 235 1994 457 461